Medifast (NYSE:MED – Get Free Report) issued an update on its fourth quarter 2024 earnings guidance on Monday morning. The company provided earnings per share guidance of 0.100-0.650 for the period, compared to the consensus earnings per share estimate of -0.180. The company issued revenue guidance of $100.0 million-$120.0 million, compared to the consensus revenue estimate of $130.0 million.
Medifast Stock Performance
MED stock traded up $0.27 during trading on Tuesday, hitting $19.08. The stock had a trading volume of 290,083 shares, compared to its average volume of 390,096. Medifast has a 1-year low of $17.07 and a 1-year high of $76.42. The company’s 50 day moving average price is $18.43 and its two-hundred day moving average price is $21.00. The stock has a market cap of $208.74 million, a price-to-earnings ratio of 7.62 and a beta of 1.13.
Medifast (NYSE:MED – Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The specialty retailer reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.50. The company had revenue of $140.16 million during the quarter, compared to analysts’ expectations of $135.45 million. Medifast had a net margin of 3.81% and a return on equity of 25.77%. During the same period in the previous year, the company earned $2.12 EPS. As a group, sell-side analysts forecast that Medifast will post 1.12 earnings per share for the current fiscal year.
Analyst Ratings Changes
Read Our Latest Stock Analysis on MED
Medifast Company Profile
Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.
See Also
- Five stocks we like better than Medifast
- The 3 Best Fintech Stocks to Buy Now
- Insider Buying Signals Upside for These 3 Stocks
- What is the Nasdaq? Complete Overview with History
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
- Stock Market Sectors: What Are They and How Many Are There?
- NXP Semiconductors Nears Rock Bottom: A Buy Signal Is Expected
Receive News & Ratings for Medifast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast and related companies with MarketBeat.com's FREE daily email newsletter.